Insulin Resistance And Sirt1 Dysregulation In Neurodegenerative Diseases
Our brains, much like the rest of our bodies, depend on a steady supply of energy, mainly from glucose. When the brain develops “insulin resistance,” its cells struggle to respond effectively to insulin, a hormone vital for absorbing glucose. This leads to an energy deficit within brain cells, even if there’s ample glucose available in the bloodstream. This energy crisis can trigger a series of problems, including heightened inflammation and damage from unstable molecules.
A key player in this process is a protein known as Sirtuin 1 (SIRT1). Consider SIRT1 a crucial regulator of cell health, involved in how cells sense energy, adapt to stress, and manage inflammation. When insulin resistance takes hold, the activity of SIRT1 in brain cells diminishes. This reduction is significant because it compromises the brain’s protective mechanisms, leading to issues such as mitochondrial failure (where the cell’s energy-producing structures malfunction), increased oxidative stress, and elevated neuroinflammation.
This interconnected problem, where insulin resistance results in SIRT1 dysfunction, creates a widespread metabolic breakdown throughout the brain. This perspective offers a new way to understand conditions like Alzheimer’s and Parkinson’s diseases, suggesting they might share a common metabolic vulnerability. Recognizing this connection paves the way for novel strategies in early diagnosis and treatment, potentially including methods that enhance insulin sensitivity, boost SIRT1 activity, or emphasize healthy lifestyle modifications.
Source: link to paper